ArticleCurrent developments in nutrition2026
Local High-Protein, Plant-Based Ready-to-Use Therapeutic Food Enhances Recovery from Malnutrition in Rats.
Article in Current developments in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infant or child malnutrition is a major public health issue. With global funding cuts and increasing incidence because of conflicts and climate change, finding cost effective and sustainable solutions is highly needed. Objectives: We conducted a preclinical study to mimic child acute malnutrition (AM) and evaluate recovery using a novel plant-based ready-to-use-therapeutic food (RUTF) made from locally available ingredients from sub-Saharan Africa. Methods: Three-week-old rats were assigned to a 6-wk experiment consisting of a 3-wk induction phase, followed by a 3-wk dietary intervention phase. During the induction phase, the rats received either a balanced diet (control) or a protein-deficient diet (to induce malnutrition). For the subsequent intervention phase, both the control and malnourished rats were switched to either a commercial peanut milk (PM) RUTF or a locally produced plant-based chickpea-sorghum-maize-soybean (ChSMS) RUTF, or remained on the same diet as the induction phase. Results: Compared with the PM formulation, the ChSMS formulation provided a higher protein content (14% compared with 10% of total energy) and greater protein quality (Protein Digestibility-Corrected Amino Acid Score of 87% compared with 69%, respectively). ChSMS was consumed in higher amounts by the rats and resulted in significantly greater body weight and length as compared with PM. In malnourished animals, ChSMS led to catch-up growth, whereas PM did not. Conclusions: These findings indicate that a locally produced, culturally acceptable, and affordable plant-based RUTF formulated with high protein quality and density may be effective in treating AM in children. Moreover, the observed reversal of stunting and subsequent catch-up growth indicate that this formulation may also be efficacious as a lipid-based supplement in addressing chronic malnutrition.This trial was registered at the Hebrew University of Jerusalem (HUJI) Authority for Biological and Biomedical Models https://animals.huji.ac.il/; https://animals.huji.ac.il/form/request-perform-research-animals-decision-if-specified-research-experiment-animals-defined-law (ABBMS) as Ethics Number AG-22-16962-3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.